Pluristem: At record low on plans for public and direct offerings

Pluri

04/04/2019 12:06

** Shares of Pluristem Therapeutics  PSTI.O  slide ~26 pct
to $0.64 premarket, set to hit a record low and erase YTD gains
    ** Co says plans to offer shares and warrants in a public
offering along with a concurrent registered direct offering
    ** Co does not disclose size of deal, the proceeds of which
it plans to use for R&D, clinical trials and other corporate
purposes
    ** Ladenburg Thalmann is sole bookrunner  urn:newsml:reuters.com:*:nASB01F39
    ** Deal comes on heels of a 3-day slide in which PSTI fell
11.2 pct to cut YTD gains to under 9 pct
    ** PSTI shares have not fallen more than 25 pct in a single
session since Jan 2011; Co market cap is $100.6 mln

 (Reporting by Savio D'Souza)
 ((RM:savio.dsouza.thomsonreuters.com@reuters.net))